Role of the pharmacist in palliative care

Progress in Palliative Care

Volumn 18, Issue 3, 2010, Pages 132-139

  Walker, Kathryn A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Clinical pharmacy; Hospice; Medication use; Pharmaceutical care; Pharmacy

Indexed keywords

DRUG USE; FAMILY; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; REVIEW; TERMINAL CARE;

EID: 77953214334     PISSN: 09699260     EISSN: 1743291X     Source Type: Journal    
DOI: 10.1179/096992610X12624290276755     Document Type: Review

References (75)

1. World Health Organization. WHO Definition of Palliative Care. 2009 [accessed 14 September 2009].
2. EuroPharm Forum. The Role of the Pharmacist in Palliative Care. 2002 .
3. LeBlanc JM, Dasta JF. Scope of international hospital pharmacy practice. Ann Pharmacother 2005; 39: 183-191.
4. FIP Council. The role of the pharmacist in the prevention and treatment of chronic disease. 2006.
5. The Society of Hospital Pharmacists of Australia. Clinical pharmacists improve patient outcomes. 2003.
6. National Consensus Project for Quality Palliative Care Task Force. Practice Guidelines for Quality Palliative Care, 2nd edn. 2009.
7. NCCN Palliative Care Panel Members. Palliative Care. NCCN Clinical Practice Guidelines in Oncology. v1.2009 edn. National Comprehensive Cancer Network, 2009; 1-50.
8. Maxwell TL, Martinez J, Knight C F. (eds) The Hospice and Palliative Medicine Approach to Life-Limiting Illness, 3rd edn. Glenview, IL: American Academy of Hospice and Palliative Medicine, 2008.
9. The IAHPC Manual of Palliative Care. 2009 [accessed 14 September 2009].
10. Tebbit P. Palliative Care 2000 - commissioning through partnership. 1999.
11. American Society of Health-System Pharmacists. ASHP statement on the pharmacist's role in hospice and palliative care. Am J Health Syst Pharm 2002; 59: 1770-1773.
12. The Society of Hospital Pharmacists of Australia. Pharmacists as part of the multidisciplinary team in GP Super Clinics. 2008.
13. Gilbar P. SHPA standards of practice for the provision of palliative care pharmacy services. J Pharm Pract Res 2006; 36: 306-308.
14. Royal Pharmaceutical Society of Great Britain. Working Party Report: pharmaceutical care of cancer patients in the community. Pharm J 1997; 258: 54-57.
15. Strasser F, Sweeney C, Willey J, Benisch-Tolley S, Palmer JL, Bruera E. Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study. J Pain Symptom Manage 2004; 27: 481-491.
16. Xue Y, Schulman-Green D, Czaplinski C, Harris D, McCorkle R. Pain attitudes and knowledge among RNs, pharmacists, and physicians on an inpatient oncology service. Clin J Oncol Nurs 2007; 11: 687-695.
17. Austwick EA, Brown LC, Goodyear KH, Brooks DJ. Pharmacist' s input into a palliative care clinic. Pharm J 2002; 268: 404-406.
18. Maeyama E, Kawa M, Miyashita M et al. Multiprofessional team approach in palliative care units in Japan. Support Care Cancer 2003; 11: 509-515.
19. Mihalyo M. Establishing palliative care services. In: Strickland JM. (ed) Palliative Pharmacy Care. Bethesda, MD: American Society of Health-System Pharmacists, 2009; 193-199.
20. Hanif N. Role of the palliative care unit pharmacist. J Palliat Care 1991; 7: 35-36.
21. Dean T W. Pharmacist as a member of the palliative care team. Can J Hosp Pharm 1987; 40: 95-96.
22. Arter SG, DuBe J, Mahoney JJ. Hospice care and the pharmacist. Am Pharm 1987; 27: 32-36.
23. Berry JI, Pulliam CC, Caiola SM, Eckel FM. Pharmaceutical services in hospices. Am J Hosp Pharm 1981; 38: 1010-1014.
24. Hammel MI, Trinca CE. Patient needs come first at Hillhaven Hospice. Pharmacy services essential for pain control. Am Pharm 1978; 18: 15-17.
25. Galt MA, Galt KA. Pharmaceutical services in hospital-based home health-care agencies - 1982. Am J Hosp Pharm 1984; 41: 2355-2359.
26. Cramer R. Opportunities for pharmacists in hospice organizations. Am J Hosp Pharm 1988; 45: 76.
27. Timmons ED. How pharmacists provide useful Rx services to hospice patients. Pharm Times 1987; 53: 88, 91, 96.
28. Whigham Jr WD, Roberts KB. Considerations when proposing consultant pharmacist services to hospice programs. Contemp Pharm Pract 1982; 5: 239-245.
29. Quigley JL, Quigley MA, Gumbhir AK. Pharmacy & hospice: partners in patient care. Am Pharm 1982; 22: 12-15.
30. Mullan PA. Pharmacy & hospice: opportunities for service. Am Pharm 1982; 22: 16-20.
31. Thompson CA. Palliative care pharmacists consider patients' psychosocial issues. Am J Health Syst Pharm 2008; 65: 500, 502.
32. Bishop MF, Stephens L, Goodrich M, Byock I. Medication kits for managing symptomatic emergencies in the home: a survey of common hospice practice. J Palliat Med 2009; 12: 37-44.
33. LeGrand SB, Tropiano P, Marx JD, Davis M P, Walsh D. Dying at home: emergency medications for terminal symptoms. Am J Hosp Palliat Care 2001; 18: 421-423.
34. Thomas K. Out-of-hours palliative care in the community: Continuing care for the dying at home. 2001.
35. Lucey M, McQuillan R, MacCallion A, Corrigan M, Flynn J, Connaire K. Access to medications in the community by patients in a palliative setting. A systems analysis. Palliat Med 2008; 22: 185-189.
36. Morrison RS, Wallenstein S, Natale DK, Senzel RS, Huang LL. 'We don't carry that' - failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med 2000; 342: 1023-1026.
37. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. Ann Pharmacother 1990; 24: 1093-1097.
38. Lee J, McPherson ML. Outcomes of recommendations by hospice pharmacists. Am J Health Syst Pharm 2006; 63: 2235-2239.
39. McPherson ML. Performing a medication regimen review in hospice and palliative care. Am J Hosp Palliat Care 2001; 18: 193-199.
40. Toscani F, Di Giulio P, Campi R et al. Off-label prescriptions in Italian hospices: a national survey. J Pain Symptom Manage 2009; 38: 365-371.
41. Goh CR. Minimising polypharmacy - a challenge in palliative care. Singapore Med J 2002; 43: 273-275.
42. Koh N Y, Koo WH. Polypharmacy in palliative care: can it be reduced? Singapore Med J 2002; 43: 279-283.
43. Twycross RG, Bergl S, John S, Lewis K. Monitoring drug use in palliative care. Palliat Med 1994; 8: 137-143.
44. Zeppetella G. How do terminally ill patients at home take their medication? Palliat Med 1999; 13: 469-475.
45. Kemp LO, Narula P, McPherson ML, Zuckerman I. Medication reconciliation in hospice: a pilot study. Am J Hosp Palliat Care 2009; 26: 193-199.
46. McQuillar R, Finlay I, Roberts D, Branch C, Forbes K, Spencer MG. The provision of a palliative care service in a teaching hospital and subsequent evaluation of that service. Palliat Med 1996; 10: 231-239.
47. Weschules DJ. Development of guidelines for palliative care pharmacotherapy. J Pain Palliat Care Pharmacother 2005; 19: 25-38.
48. Scarpaci LT, Tsoukleris MG, McPherson ML. Assessment of hospice nurses' technique in the use of inhalers and nebulizers. J Palliat Med 2007; 10: 665-676.
49. Lycan J, Grauer P, Mihalyo M, Houchen B. Improving efficacy, efficiency and economics of hospice individualized drug therapy. Am J Hosp Palliat Care 2002; 19: 135-138.
50. Snapp J, Kelley D, Gutgsell TL. Creating a hospice pharmacy and therapeutics committee. Am J Hosp Palliat Care 2002; 19: 129-134.
51. Nowels D, Kutner JS, Kassner C, Beehler C. Hospice pharmaceutical cost trends. Am J Hosp Palliat Care 2004; 21: 297-302.
52. Cheung L, Fitch K, Pyenson B. The Costs of Hospice Care: An Actuarial Evaluation of the Medicare Hospice Benefit. 2001.
53. Guttierrez RE, Alvarez C, Alvarez R, Hernandez J, Godinez J, Lopez J. Pharmaceutical services in a Mexican pain relief and palliative care institute. Pharm Practice 2007; 5: 174-178.
54. Atayee RS, Best BM, Daniels CE. Development of an ambulatory palliative care pharmacist practice. J Palliat Med 2008; 11: 1077-1082.
55. Diment MM, Evans BL. Implementation of a pharmaceutical care practice model for palliative care. Can J Hosp Pharm 1995; 48: 228-237.
56. Needham DS, Wong IC, Campion PD, Hull and East Riding Pharmacy Development Group. Evaluation of the effectiveness of UK community pharmacists' interventions in community palliative care. Palliat Med 2002; 16: 219-225.
57. Lucas C, Glare PA, Sykes J V. Contribution of a liaison clinical pharmacist to an inpatient palliative care unit. Palliat Med 1997; 11: 209-216.
58. Myotoku M, Murayama Y, Nakanishi A et al. Assessment of palliative care team activities-survey of medications prescribed immediately before and at the beginning of opioid usage. Yakugaku Zasshi 2008; 128: 299-304.
59. Herndon CM, Jackson 2nd K, Fike DS, Woods T. End-of-life care education in United States pharmacy schools. Am J Hosp Palliat Care 2003; 20: 340-344.
60. Bookwalter TC. Formal review of end-of-life care content in pharmacotherapy texts. J Palliat Med. 2000; 3: 397.
61. Herndon CM, Fike DS, Anderson AC, Dole EJ. Pharmacy student training in United States hospices. Am J Hosp Palliat Care 2001; 18: 181-186.
62. Aragon FD, Forman WB, Dole EJ. Description of a palliative care/hospice clerkship for entry-level doctor of pharmacy students. J Am Pharm Assoc (Wash) 2002; 42: 515-517.
63. Baron MF. Death and dying. Am J Pharm Educ 1998; 62: 220-222.
64. Sylvester RK, Roberg J, Roden W, Smithson K. A hospice-based advanced pharmacy experience. Am J Pharm Educ 2009; 73: 44.
65. Cardoni JB. How pharmacy students learn to serve on the hospice team. Pharm Times 1986; August: 86-91.
66. Bookwalter TC, Rabow M W, McPhee SJ. Content on end-of-life care in major pharmacy textbooks. Am J Health Syst Pharm 2003; 60: 1246-1250.
67. Schrader SL, Nelson ML, Eidsness L et al. Education in end-of-life care: bridging disciplinary and institutional boundaries. J Uni South Dakota School Med 2005; September: 379-388.
68. Greenwald BD, Narcessian EJ. Opioids for managing patients with chronic pain: community pharmacists' perspectives and concerns. J Pain Symptom Manage 1999; 17: 369-375.
69. McIntyre WJ, Hopkins DD, Wolfe JJ. Assessing pharmacists' knowledge of cancer pain. J Pharm Care Pain Symptom Control 2000; 8: 75-83.
70. Furstenberg CT, Ahles TA, Whedon MB et al. Knowledge and attitudes of health-care providers toward cancer pain management: a comparison of physicians, nurses, and pharmacists in the state of New Hampshire. J Pain Symptom Manage 1998; 15: 335-349.
71. Hussainy S Y, Marriott JL, Nation RL. Assessing medication knowledge of Australian palliative cancer care patients and caregivers and their interactions with pharmacists. J Palliat Med 2009; 12: 769.
72. Suh ES, Bartlett G, Inguanti M, Folstad J. Evaluation of a pharmacist pain management education program and associated medication use in a palliative care population. AmJHealth Syst Pharm 2004; 61: 277-280.
73. von Gunten CF, Martinez J, Neely KJ, Twaddle M, Preodor M. Clinical experience in hospice and palliative medicine for clinicians in practice. J Palliat Med 1998; 1: 249-255.
74. ASHP Online Residency Directory. 2009 .
75. American Society of Pain Educators. Candidate Handbook; Application and Registration Instructions for the Certified Pain Educator (CPE) Examination. 2009 .